Trial Profile
Randomised phase III trial of De Gramont schedule 5-fluorouracil and leucovorin plus irinotecan versus single agent irinotecan, plus or minus celecoxib in patients with previously treated metastatic colorectal cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms DaVINCI
- 07 Dec 2010 Trial location (Australia) identified as reported by Australian New Zealand Clinical Trials Registry.
- 07 Dec 2010 New source identified and integrated (Australian New Zealand Clinical Trials Registry).
- 05 Nov 2010 New trial record.